Autolus Therapeutics Ltd Earnings

The next earnings date for Autolus Therapeutics Ltd is August 12, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Autolus Therapeutics Ltd Earnings

Report DateEstimated Earnings Per Share
10/30/2025$-0.23
08/12/2025$-0.23

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Autolus Therapeutics Ltd Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
05/08/2025---$-0.26-4.19%
11/12/2024---$-0.31-42.01%
08/08/2024Before Market$-0.22-15.79%
05/17/2024Before Market$-0.24-380.00%
03/14/2024Before Market$-0.45-80.00%
11/02/2023After Market$-0.26-4.00%
08/03/2023Before Market$-0.26-18.18%
05/04/2023Before Market$-0.2314.81%
03/07/2023Before Market$-0.2314.81%
11/03/2022Before Market$-0.47-2.17%
08/04/2022Before Market$-0.46-9.52%
05/05/2022Before Market$-0.4114.58%
03/10/2022Before Market$-0.51-10.87%
11/03/2021Before Market$-0.477.84%
08/05/2021Before Market$-0.476.00%
05/06/2021Before Market$-0.5213.33%
03/04/2021Before Market$-0.83-7.79%
11/05/2020Before Market$-0.72-1.41%
08/06/2020Before Market$-0.6212.68%
05/07/2020Before Market$-0.6018.92%
03/03/2020Before Market$-0.84-13.51%
11/07/2019Before Market$-0.6127.38%
08/08/2019Before Market$-0.6514.47%
05/14/2019Before Market$-0.69-18.97%
02/25/2019Before Market$-0.5221.21%
09/26/2018Before Market$-0.84-34.68%
06/22/2018After Market$-0.57---

More About Autolus Therapeutics Ltd

Website
https://www.autolus.com
Country
USA
Full Time Employees
647

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases in United Kingdom and internationally. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1 and TRBC2; AUTO6NG, a programmed T cell investigational therapy targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate to treat multiple myeloma. It focuses on developing AUTO5, a preclinical TRBC2 programmed T cell product candidate for the treatment of peripheral T-cell lymphoma. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.

“Autolus Therapeutics Ltd Earnings” Can Refer to the Autolus Therapeutics Ltd Earnings Date

Some people say “Autolus Therapeutics Ltd earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Autolus Therapeutics Ltd position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Autolus Therapeutics Ltd Stock on the Earnings Date

If you own Autolus Therapeutics Ltd stock (AUTL) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Autolus Therapeutics Ltd might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Autolus Therapeutics Ltd shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Autolus Therapeutics Ltd Earnings

You can contact us any time if you would like to ask questions about Autolus Therapeutics Ltd earnings or anything else related to the stock market.